Ozempic (R) was approved by Health Canada in 2018. Ozempic (R) is indicated for the once-weekly treatment of adult patients with type 2 diabetes mellitus to improve glycemic control.

Long-Term Effects of Ozempic This article was reviewed by Lynn Marie Morski, MD, JD. You may have heard about — or maybe even ...

More than half of Ozempic users prescribed the drug for obesity alone are stopping or reducing their doses within a year, driven by a collision of gastrointestinal side effects, steep out-of-pocket ...

Downside to dropping pounds? The new pill form of popular GLP-1 drugs contains a compound that could cause troubling side ...

A newly reported side effect of the popular GLP-1 weight loss drugs may be its most annoying yet. From “Ozempic ears” and “Ozempic butt” to “Ozempic breasts” and “Ozempic face,” people have given many ...

Alternatives to Ozempic for Weight Loss This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic is an ...

Generic versions of Novo Nordisk A/S’s hit shots Ozempic and Wegovy could be sold for under $3 a month, a new study showed, underscoring their potential to unlock global access to powerful weight-loss ...

Once used exclusively for managing diabetes, celebrities' use of weight loss medications like Ozempic, Mounjaro, Wegovy, ...

Zydus Lifesciences will roll out generic semaglutide injections in India post-patent expiry, using a reusable single-pen ...

Users of the popular GLP-1 have flagged a new concern: the Ozempic itch. Experts break down everything you need to know below about getting red, itchy patches on your skin while on the drug.

The price of the popular GLP-1 medications will be cut, starting in January of 2027, manufacturer Novo Nordisk said in a ...

Novo Nordisk announced today that Health Canada has approved Ozempic® (semaglutide injection) to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction ...